Tender detail
Open-house pharmaceutical rebate agreements for ivermectin (ATC D11AX22)
Summary
AOK Bayern is offering non-exclusive pharmaceutical rebate agreements for the active ingredient ivermectin (ATC D11AX22) to interested pharmaceutical companies. The agreements may commence from 1 January 2027, run until 31 December 2028, and may be concluded up to 3 November 2028. An agreement will automatically cease to apply for the relevant period if a nationwide or state-level rebate agreement for the same active ingredient takes effect.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.